These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

446 related items for PubMed ID: 15551359

  • 1. Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort.
    Fournier A, Berrino F, Riboli E, Avenel V, Clavel-Chapelon F.
    Int J Cancer; 2005 Apr 10; 114(3):448-54. PubMed ID: 15551359
    [Abstract] [Full Text] [Related]

  • 2. Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden.
    Olsson HL, Ingvar C, Bladström A.
    Cancer; 2003 Mar 15; 97(6):1387-92. PubMed ID: 12627501
    [Abstract] [Full Text] [Related]

  • 3. Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in Europe.
    Stahlberg C, Pedersen AT, Lynge E, Andersen ZJ, Keiding N, Hundrup YA, Obel EB, Ottesen B.
    Int J Cancer; 2004 May 01; 109(5):721-7. PubMed ID: 14999781
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Hormone replacement therapy in menopause and risk of breast cancer].
    Clavel-Chapelon F, Hill C.
    Presse Med; 2000 Oct 21; 29(31):1688-93. PubMed ID: 11094609
    [Abstract] [Full Text] [Related]

  • 6. Menopause hormone replacement therapy and cancer risk: an Italian record linkage investigation.
    Corrao G, Zambon A, Conti V, Nicotra F, La Vecchia C, Fornari C, Cesana G, Contiero P, Tagliabue G, Nappi RE, Merlino L.
    Ann Oncol; 2008 Jan 21; 19(1):150-5. PubMed ID: 17785762
    [Abstract] [Full Text] [Related]

  • 7. Hormone replacement therapy use and variations in the risk of breast cancer.
    Opatrny L, Dell'Aniello S, Assouline S, Suissa S.
    BJOG; 2008 Jan 21; 115(2):169-75; discussion 175. PubMed ID: 18081598
    [Abstract] [Full Text] [Related]

  • 8. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women.
    Stanford JL, Weiss NS, Voigt LF, Daling JR, Habel LA, Rossing MA.
    JAMA; 1995 Jul 12; 274(2):137-42. PubMed ID: 7596001
    [Abstract] [Full Text] [Related]

  • 9. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
    van Leeuwen FE.
    Acta Endocrinol (Copenh); 1991 Jul 12; 125 Suppl 1():13-26. PubMed ID: 1801500
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study.
    Renoux C, Dell'aniello S, Garbe E, Suissa S.
    BMJ; 2010 Jun 03; 340():c2519. PubMed ID: 20525678
    [Abstract] [Full Text] [Related]

  • 15. Continuous combined hormone replacement therapy and risk of endometrial cancer.
    Hill DA, Weiss NS, Beresford SA, Voigt LF, Daling JR, Stanford JL, Self S.
    Am J Obstet Gynecol; 2000 Dec 03; 183(6):1456-61. PubMed ID: 11120510
    [Abstract] [Full Text] [Related]

  • 16. Use of hormone replacement therapy and risk of breast cancer: nested case-control studies using the QResearch and CPRD databases.
    Vinogradova Y, Coupland C, Hippisley-Cox J.
    BMJ; 2020 Oct 28; 371():m3873. PubMed ID: 33115755
    [Abstract] [Full Text] [Related]

  • 17. Postmenopausal hormone therapy and breast cancer.
    Prescrire Int; 2009 Apr 28; 18(100):66-7. PubMed ID: 19585723
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Oral contraceptives, hormone replacement therapy and breast cancer risk: a cohort study of 16 928 women 48 years and older.
    Thorbjarnardottir T, Olafsdottir EJ, Valdimarsdottir UA, Olafsson O, Tryggvadottir L.
    Acta Oncol; 2014 Jun 28; 53(6):752-8. PubMed ID: 24460068
    [Abstract] [Full Text] [Related]

  • 20. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR, Gadducci A, Gambacciani M.
    Climacteric; 2001 Sep 28; 4(3):181-93. PubMed ID: 11588941
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.